Back to Search
ROBERT MARTUZA, MD
MD
Neurological Surgery Physician
NPI: 1861482135Individual
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
39007(MA)
Research & Publications (20)
Conditionally replicating herpes vectors for cancer therapy.
PMID 10749560·J Clin Invest·2000
6-review
Hypoxia enhances the replication of oncolytic herpes simplex virus.
PMID 18957963·Mol Ther·2009
7-preclinical
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy.
PMID 19264968·Proc Natl Acad Sci U S A·2009
7-preclinical
Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
PMID 19145156·Neurosurgery·2009
8-other
Genetic determinants of hearing loss associated with vestibular schwannomas.
PMID 19546833·Otol Neurotol·2009
8-other
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
PMID 19351838·Cancer Res·2009
7-preclinical
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
PMID 19197321·Cancer Gene Ther·2009
8-other
Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.
PMID 19047097·Clin Cancer Res·2008
7-preclinical
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
PMID 18231723·J Neurooncol·2008
8-other
Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.
PMID 18388912·Mol Ther·2008
7-preclinical
Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.
PMID 18988803·Am J Pathol·2008
7-preclinical
Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-Akt targeting molecular therapeutics.
PMID 17908985·Clin Cancer Res·2007
7-preclinical
Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
PMID 17909046·Cancer Res·2007
7-preclinical
Oncolytic herpes simplex virus therapy for peripheral nerve tumors.
PMID 17613221·Neurosurg Focus·2007
6-review
Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta.
PMID 17304235·Cancer Gene Ther·2007
7-preclinical
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses.
PMID 17909049·Cancer Res·2007
7-preclinical
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
PMID 17234749·Cancer Res·2007
7-preclinical
Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
PMID 17047077·Cancer Res·2006
7-preclinical
Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
PMID 17121900·Clin Cancer Res·2006
7-preclinical
Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
PMID 17380741·Clin Neurosurg·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST
BOSTON, MA 02114 - Phone
- (617) 726-8581
Quick Facts
- NPI
- 1861482135
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile